ScienceEstimationIntervention timing

Will this therapy work in the time that is left?

MOISS, our Multi-Organ Intervention State Space, sets the time an organ has before it reaches a critical threshold against the time a therapy needs to take effect. Choose an organ system and a kind of therapy to see how the margin between the two becomes a grade.

Organ system

Therapy

The durations are illustrative and are not taken from any patient.

The question

Time left and time to effect

The first clock belongs to the organ. Once we know where a biomarker stands and how fast it is moving, the time it has left is the remaining distance to its critical threshold divided by that speed, which means the clock runs faster whenever the organ deteriorates faster.

The second clock belongs to the therapy, because every drug and every procedure needs its own time to reach an effect, which pharmacology sets however urgent the situation has become.

What it adds

What a severity score does not show

The scores used at the bedside today summarise how far a patient's values have moved from normal at this moment. Two patients can share the same score while one is holding steady and the other is hours from a threshold, and a score alone cannot tell them apart.

Because MOISS works from the speed as well as the level, it can separate those two patients, and it can give the same therapy a different grade an hour later if the organ has picked up pace in between.

The grades

What the six grades mean

The grade comes from the margin measured against the therapy's own onset time, since half an hour to spare is generous for a drug that acts in minutes and thin for one that needs most of a day.

The grades in the middle exist because lateness is rarely all or nothing. A therapy that lands shortly after the threshold can still recover part of what was lost, and one that lands later may be worth giving alongside a bridging therapy that buys the organ time.

PROPHYLACTICThe therapy takes effect with more than its own onset time to spare.
ON_TIMEIt takes effect before the organ reaches the threshold.
PARTIALIt takes effect shortly after the threshold is crossed.
MARGINALIt takes effect later still, in the period where bridging therapy may help.
FUTILEIt takes effect well past the threshold, with little left to recover.
TOO_LATEIt cannot take effect before the damage is irreversible.

Evidence

How far it has been tested

So far the grading has been tested retrospectively, against records from public critical care databases. A prospective study at the bedside is still ahead, and until it is done the grades should be read as research.

We review each request and reply by email.

Tested
Retrospectively, against records from public critical care databases.
Still ahead
A prospective study at the bedside.
Status
Research, awaiting a prospective study before any clinical use.
Aethryva Deeptech

Paper request

Request the paper

Fill in the form below. We review each request and send the paper by email.

Aethryva Deeptech Pvt Ltd, Hyderabad. Your details are handled under our privacy policy.